232 related articles for article (PubMed ID: 34741449)
1. Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma.
Shi H; Han L; Zhao J; Wang K; Xu M; Shi J; Dong Z
Cancer Med; 2021 Dec; 10(24):8944-8960. PubMed ID: 34741449
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
3. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
Chen M; Wang X; Wang W; Gui X; Li Z
Front Immunol; 2022; 13():829057. PubMed ID: 35833114
[TBL] [Abstract][Full Text] [Related]
4. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing.
Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z
Front Immunol; 2023; 14():1174762. PubMed ID: 37287976
[TBL] [Abstract][Full Text] [Related]
6. Identification of Stem Cell-related Gene Markers by Comprehensive Transcriptome Analysis to Predict the Prognosis and Immunotherapy of Lung Adenocarcinoma.
Lai H; Wen X; Peng Y; Zhang L
Curr Stem Cell Res Ther; 2024; 19(5):743-754. PubMed ID: 37605423
[TBL] [Abstract][Full Text] [Related]
7. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037
[TBL] [Abstract][Full Text] [Related]
8. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
[TBL] [Abstract][Full Text] [Related]
9. Identification of Cancer Stem Cell-related Gene by Single-cell and Machine Learning Predicts Immune Status, Chemotherapy Drug, and Prognosis in Lung Adenocarcinoma.
Yang C; Zhang J; Xie J; Li L; Zhao X; Liu J; Wang X
Curr Stem Cell Res Ther; 2024; 19(5):767-780. PubMed ID: 37455453
[TBL] [Abstract][Full Text] [Related]
10. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
[TBL] [Abstract][Full Text] [Related]
11. Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells.
Wan R; Liao H; Liu J; Zhou L; Yin Y; Mu T; Wei J
Biomed Res Int; 2022; 2022():4404406. PubMed ID: 35480140
[TBL] [Abstract][Full Text] [Related]
12. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
13. Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma.
Wang H; Wang Y; Luo W; Zhang X; Cao R; Yang Z; Duan J; Wang K
BMC Pulm Med; 2022 Dec; 22(1):463. PubMed ID: 36471379
[TBL] [Abstract][Full Text] [Related]
14. The Tumor Stemness Indice mRNAsi can Act as Molecular Typing Tool for Lung Adenocarcinoma.
Yi Y; Liu X; Gao H; Qin S; Xu J; Ma F; Guan M
Biochem Genet; 2023 Dec; 61(6):2401-2424. PubMed ID: 37100923
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications.
Xu F; He L; Zhan X; Chen J; Xu H; Huang X; Li Y; Zheng X; Lin L; Chen Y
Aging (Albany NY); 2020 Nov; 12(24):25275-25293. PubMed ID: 33234739
[TBL] [Abstract][Full Text] [Related]
16. Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.
Han L; Shi H; Luo Y; Sun W; Li S; Zhang N; Jiang X; Gong Y; Xie C
Cancer Med; 2020 Dec; 9(24):9581-9594. PubMed ID: 33098370
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
Lai J; Lin X; Zheng H; Xie B; Fu D
BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
[TBL] [Abstract][Full Text] [Related]
18. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
20. Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma.
Han T; Liu Y; Zhou J; Guo J; Xing Y; Xie J; Bai Y; Wu J; Hu D
Sci Rep; 2024 Jan; 14(1):1692. PubMed ID: 38243040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
